FOLH1 and metastatic prostate carcinoma: Compared with conventional imaging, prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT) can detect metastatic prostate cancer in some uncommon sites with better results than CT, bone scans, and MRI, especially at lower PSA levels (33).